Valuation: PolyPeptide Group AG

Market Cap 1.57B 1.76B 1.45B 1.31B 2.46B 167B 2.5B 17.46B 6.91B 87.48B 6.6B 6.46B 276B P/E 2026 *
58.6x
P/E 2027 * 31.1x
Enterprise Value 1.67B 1.87B 1.54B 1.4B 2.62B 178B 2.66B 18.58B 7.36B 93.11B 7.03B 6.88B 294B EV / Sales 2026 *
3.33x
EV / Sales 2027 * 2.95x
Free-Float
39.12%
Yield 2026 *
-
Yield 2027 * 0.14%
1 day-0.45%
Current month-0.34%
1 month-0.45%
3 months+0.46%
6 months+23.11%
Current year+68.39%
1 week 43.65
Extreme 43.65
44.25
1 month 43.25
Extreme 43.25
44.3
Current year 23.1
Extreme 23.1
50.1
1 year 21.8
Extreme 21.8
50.1
3 years 13.22
Extreme 13.22
50.1
5 years 13.22
Extreme 13.22
146
10 years 13.22
Extreme 13.22
147.4
Manager TitleAgeSince
Chief Executive Officer 54 2023-04-11
Director of Finance/CFO 54 2024-01-01
Chief Tech/Sci/R&D Officer 54 -
Director TitleAgeSince
Director/Board Member 73 2005-12-31
Chairman 69 2021-03-31
Director/Board Member 62 2020-12-31
Date Insider Type Main position Quantity % Market Cap. Importance
11/13/23 Buy 2,500 0.0075%
10/12/23 Buy 159,959 0.4829%
4/6/23 Buy 45,842 0.1384%
Change 5-day change 1-year change 3-year change Capi.($)
-0.45%0.00%+69.04%+165.56% 1.76B
-2.54%+1.31%+54.27%+114.96% 1,135B
-1.42%+3.23%+38.56%+74.44% 636B
+0.16%+0.08%+25.29%+95.23% 505B
-0.31%+3.09%+44.14%+64.80% 378B
-1.34%-0.47%+66.04%+41.00% 358B
-0.68%+2.65%+22.98%+50.39% 295B
-1.20%+3.04%+2.33%+22.86% 266B
-1.79%+1.57%+50.56%+59.08% 237B
-0.73%-0.10%+29.02%+99.67% 193B
Average -1.03%+1.95%+40.22%+78.80% 400.61B
Weighted average by Cap. -1.35%+2.66%+41.04%+79.79%

Financials

2026 *2027 *
Net sales 502M 562M 464M 420M 786M 53.36B 799M 5.58B 2.21B 27.95B 2.11B 2.06B 88.13B 576M 645M 532M 482M 902M 61.23B 917M 6.4B 2.54B 32.08B 2.42B 2.37B 101B
Net income 23.5M 26.32M 21.71M 19.68M 36.81M 2.5B 37.42M 261M 103M 1.31B 98.78M 96.68M 4.13B 45.23M 50.65M 41.78M 37.86M 70.84M 4.81B 72.01M 503M 199M 2.52B 190M 186M 7.94B
Net Debt 101M 113M 93.27M 84.52M 158M 10.73B 161M 1.12B 444M 5.62B 424M 415M 17.73B 131M 147M 121M 110M 205M 13.92B 208M 1.46B 576M 7.29B 550M 538M 22.99B
Projected Income Statement - Annual - PolyPeptide Group AG
Logo PolyPeptide Group AG
Polypeptide Group AG is a Switzerland-based Contract Development & Manufacturing Organization (CDMO) focusing on proprietary and generic GMP-grade peptides used by pharmaceutical and biotech companies in approved pharmaceutical products, drugs in clinical development as well as in generic products.
Employees
1,460
Date Price Change Volume
26-10-23 CHF 43.95 -0.45% 16,072
26-10-22 CHF 44.15 +0.11% 6,162
26-10-21 CHF 44.10 +0.11% 11,409
26-10-20 CHF 44.05 0.00% 16,136
26-10-19 CHF 44.05 +0.23% 35,561
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - PolyPeptide Group AG
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
6
Last Close Price
47.57EUR
Average target price
45.99EUR
Spread / Average Target
-3.34%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - PolyPeptide Group AG
  1. Stock Market
  2. Stocks
  3. PPGN Stock